Package 70518-4165-0

{"route": ["ORAL"], "spl_id": "47cc41df-209b-9d3e-e063-6394a90a5c91", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["864V2Q084H", "0J48LPH2TH", "6M97XTV3HD"], "rxcui": ["1000001"], "spl_set_id": ["57ffeef7-bfa8-4f92-aadc-23cd00022607"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4165-0)", "package_ndc": "70518-4165-0", "marketing_start_date": "20240822"}], "brand_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "product_id": "70518-4165_47cc41df-209b-9d3e-e063-6394a90a5c91", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "70518-4165", "generic_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA206137", "marketing_category": "ANDA", "marketing_start_date": "20240822", "listing_expiration_date": "20271231"}